Medicine made with CRISPR?

March saw the first trial of a CRISPRcreated medical treatment. The low-cost gene-editing technology was used to make a potential treatment for Leber’s congenital amaurosis 10, a leading cause of blindness in children. The CRISPR se”uence has been designed to cut out the gene mutation that disables lightsensing cells. The trial, carried by pharmaceutical companies cditas Medicine and Allergan, hasn’t yet published its results.